May 10, 2023Open Access

Racial Inequality in Receipt of Medications for Opioid Use Disorder

Key Points

Key points are not available for this paper at this time.

Abstract

Racial and ethnic differences in the receipt of medications to treat OUD after an index event related to this disorder among patients with disability were substantial and did not change over time. The high incidence of ambulatory visits in all groups showed that disparities persisted despite frequent health care contact. (Funded by the National Institute on Drug Abuse and the National Institute on Aging.).

Bookmark

View Full Paper

Cite This Study

Barnett et al. (Wed,) studied this question.

synapsesocial.com/papers/69de7d927ed287395e55927f https://doi.org/https://doi.org/10.1056/nejmsa2212412

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Buprenorphine Treatment Divide by Race/Ethnicity and Payment2019 · 468 citations
2Benzodiazepines are Prescribed More Frequently to Patients Already at Risk for Benzodiazepine-Related Adverse Events in Primary Care2016 · 96 citations
3Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion2018 · 108 citations
4The role of perceived treatment need in explaining racial/ethnic disparities in the use of substance abuse treatment services2020 · 39 citations
51-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial2003 · 474 citations

Bookmark

View Full Paper